Bulimia Nervosa Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Bulimia Nervosa Market to 2027 - Global Analysis and Forecasts By Type (Drug Therapy, Psychotherapy); Distribution Channel (Hospital Pharmacies, Retail Pharmacies) and Geography

Report Code: TIPRE00005404 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Bulimia nervosa is a serious eating disorder characterized by frequent episode of binge eating follow by extreme efforts to avoid gaining weight, often by vomiting or exercising to excess. Eating disorder are mental health problem that causes extreme and dangerous eating behavior. Occurrence of bulimia nervosa are depends on alcoholism, cardiovascular & diabetes disease. It is commonly found in more in female then male.

MARKET DYNAMICS
The bulimia nervosa market is expected to grow during the forecast period owing to the key driving factors such as changing life style and more consumption of alcohol as well as rising psychic disease, increase no of diabetes and cardiovascular disease, awareness related to healthcare and others. In addition, various players in the emerging market have strong pipeline product and high potential which are anticipated to create several growth opportunities for the market during the forecast period.

MARKET SCOPE
The "Global Bulimia Nervosa Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of benign prostatic hyperplasia therapeutics with detailed market segmentation by type, distribution channel and geography. The global bulimia nervosa market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading the bulimia nervosa market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global bulimia nervosa market is segmented on the basis of type, and distribution channel. Based on products, the market is segmented as drug therapy and psychotherapy. On the basis of distribution channel, the global bulimia nervosa market is segmented into hospital pharmacies and retail pharmacies
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global bulimia nervosa market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The bulimia nervosa market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting bulimia nervosa market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the bulimia nervosa market in these regions.

MARKET PLAYERS
The reports cover key developments in the bulimia nervosa market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from bulimia nervosa market are anticipated to lucrative growth opportunities in the future with the rising demand for bulimia nervosa in the global market. Below mentioned is the list of few companies engaged in the bulimia nervosa market.

The report also includes the profiles of key bulimia nervosa market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • JOHNSON and JOHNSON SERVICES, INC
  • Eli Lilly and Company
  • Par Pharmaceutical
  • Dr. Reddy's Laboratories Ltd
  • Lupin Pharmaceuticals, Inc
  • Lannett
  • Sun Pharmaceutical Industries Ltd
  • Mylan N.V
  • Sandoz International GmbH
  • Nivagen Pharmaceuticals
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Bulimia Nervosa Market - By Type
1.3.2 Bulimia Nervosa Market - By Distribution Channel
1.3.3 Bulimia Nervosa Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BULIMIA NERVOSA MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BULIMIA NERVOSA MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BULIMIA NERVOSA MARKET - GLOBAL MARKET ANALYSIS
6.1. BULIMIA NERVOSA - GLOBAL MARKET OVERVIEW
6.2. BULIMIA NERVOSA - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BULIMIA NERVOSA MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. DRUG THERAPY
7.3.1. Overview
7.3.2. Drug Therapy Market Forecast and Analysis
7.3.3. Antidepressants Market
7.3.3.1. Overview
7.3.3.2. Antidepressants Market Forecast and Analysis
7.3.4. Other Market
7.3.4.1. Overview
7.3.4.2. Other Market Forecast and Analysis
7.4. PSYCHOTHERAPY
7.4.1. Overview
7.4.2. Psychotherapy Market Forecast and Analysis
7.4.3. Maudsley Family Therapy Market
7.4.3.1. Overview
7.4.3.2. Maudsley Family Therapy Market Forecast and Analysis
7.4.4. Other Market
7.4.4.1. Overview
7.4.4.2. Other Market Forecast and Analysis
8. BULIMIA NERVOSA MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
9. BULIMIA NERVOSA MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Bulimia Nervosa Market Overview
9.1.2 North America Bulimia Nervosa Market Forecasts and Analysis
9.1.3 North America Bulimia Nervosa Market Forecasts and Analysis - By Type
9.1.4 North America Bulimia Nervosa Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Bulimia Nervosa Market Forecasts and Analysis - By Countries
9.1.5.1 United States Bulimia Nervosa Market
9.1.5.1.1 United States Bulimia Nervosa Market by Type
9.1.5.1.2 United States Bulimia Nervosa Market by Distribution Channel
9.1.5.2 Canada Bulimia Nervosa Market
9.1.5.2.1 Canada Bulimia Nervosa Market by Type
9.1.5.2.2 Canada Bulimia Nervosa Market by Distribution Channel
9.1.5.3 Mexico Bulimia Nervosa Market
9.1.5.3.1 Mexico Bulimia Nervosa Market by Type
9.1.5.3.2 Mexico Bulimia Nervosa Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Bulimia Nervosa Market Overview
9.2.2 Europe Bulimia Nervosa Market Forecasts and Analysis
9.2.3 Europe Bulimia Nervosa Market Forecasts and Analysis - By Type
9.2.4 Europe Bulimia Nervosa Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Bulimia Nervosa Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Bulimia Nervosa Market
9.2.5.1.1 Germany Bulimia Nervosa Market by Type
9.2.5.1.2 Germany Bulimia Nervosa Market by Distribution Channel
9.2.5.2 France Bulimia Nervosa Market
9.2.5.2.1 France Bulimia Nervosa Market by Type
9.2.5.2.2 France Bulimia Nervosa Market by Distribution Channel
9.2.5.3 Italy Bulimia Nervosa Market
9.2.5.3.1 Italy Bulimia Nervosa Market by Type
9.2.5.3.2 Italy Bulimia Nervosa Market by Distribution Channel
9.2.5.4 Spain Bulimia Nervosa Market
9.2.5.4.1 Spain Bulimia Nervosa Market by Type
9.2.5.4.2 Spain Bulimia Nervosa Market by Distribution Channel
9.2.5.5 United Kingdom Bulimia Nervosa Market
9.2.5.5.1 United Kingdom Bulimia Nervosa Market by Type
9.2.5.5.2 United Kingdom Bulimia Nervosa Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Bulimia Nervosa Market Overview
9.3.2 Asia-Pacific Bulimia Nervosa Market Forecasts and Analysis
9.3.3 Asia-Pacific Bulimia Nervosa Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Bulimia Nervosa Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Bulimia Nervosa Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Bulimia Nervosa Market
9.3.5.1.1 Australia Bulimia Nervosa Market by Type
9.3.5.1.2 Australia Bulimia Nervosa Market by Distribution Channel
9.3.5.2 China Bulimia Nervosa Market
9.3.5.2.1 China Bulimia Nervosa Market by Type
9.3.5.2.2 China Bulimia Nervosa Market by Distribution Channel
9.3.5.3 India Bulimia Nervosa Market
9.3.5.3.1 India Bulimia Nervosa Market by Type
9.3.5.3.2 India Bulimia Nervosa Market by Distribution Channel
9.3.5.4 Japan Bulimia Nervosa Market
9.3.5.4.1 Japan Bulimia Nervosa Market by Type
9.3.5.4.2 Japan Bulimia Nervosa Market by Distribution Channel
9.3.5.5 South Korea Bulimia Nervosa Market
9.3.5.5.1 South Korea Bulimia Nervosa Market by Type
9.3.5.5.2 South Korea Bulimia Nervosa Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Bulimia Nervosa Market Overview
9.4.2 Middle East and Africa Bulimia Nervosa Market Forecasts and Analysis
9.4.3 Middle East and Africa Bulimia Nervosa Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Bulimia Nervosa Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Bulimia Nervosa Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Bulimia Nervosa Market
9.4.5.1.1 South Africa Bulimia Nervosa Market by Type
9.4.5.1.2 South Africa Bulimia Nervosa Market by Distribution Channel
9.4.5.2 Saudi Arabia Bulimia Nervosa Market
9.4.5.2.1 Saudi Arabia Bulimia Nervosa Market by Type
9.4.5.2.2 Saudi Arabia Bulimia Nervosa Market by Distribution Channel
9.4.5.3 U.A.E Bulimia Nervosa Market
9.4.5.3.1 U.A.E Bulimia Nervosa Market by Type
9.4.5.3.2 U.A.E Bulimia Nervosa Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Bulimia Nervosa Market Overview
9.5.2 South and Central America Bulimia Nervosa Market Forecasts and Analysis
9.5.3 South and Central America Bulimia Nervosa Market Forecasts and Analysis - By Type
9.5.4 South and Central America Bulimia Nervosa Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Bulimia Nervosa Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Bulimia Nervosa Market
9.5.5.1.1 Brazil Bulimia Nervosa Market by Type
9.5.5.1.2 Brazil Bulimia Nervosa Market by Distribution Channel
9.5.5.2 Argentina Bulimia Nervosa Market
9.5.5.2.1 Argentina Bulimia Nervosa Market by Type
9.5.5.2.2 Argentina Bulimia Nervosa Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. BULIMIA NERVOSA MARKET, KEY COMPANY PROFILES
11.1. JOHNSON AND JOHNSON SERVICES, INC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ELI LILLY AND COMPANY
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. PAR PHARMACEUTICAL
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. DR. REDDY'S LABORATORIES LTD
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LUPIN PHARMACEUTICALS, INC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. LANNETT
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SUN PHARMACEUTICAL INDUSTRIES LTD
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MYLAN N.V
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SANDOZ INTERNATIONAL GMBH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. NIVAGEN PHARMACEUTICALS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. JOHNSON and JOHNSON SERVICES, INC
2. Eli Lilly and Company
3. Par Pharmaceutical
4. Dr. Reddy's Laboratories Ltd
5. Lupin Pharmaceuticals, Inc
6. Lannett
7. Sun Pharmaceutical Industries Ltd
8. Mylan N. V
9. Sandoz International GmbH
10. Nivagen Pharmaceuticals
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book